Article info

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

Authors

  1. Correspondence to Professor Paul Emery, Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK; p.emery{at}leeds.ac.uk
View Full Text

Citation

Emery P, Sebba A, Huizinga TWJ
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

Publication history

  • Received February 18, 2013
  • Revised June 20, 2013
  • Accepted July 9, 2013
  • First published August 5, 2013.
Online issue publication 
November 04, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.